Figure 2.
Approved molecules and those in the pipeline (currently undergoing phase 3 trials) for type 2 diabetes and/or obesity.
GIP: glucose-dependent insulinotropic polypeptide, GLP-1: glucagon-like peptide-1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.